Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 11:37 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1225–1248 of 1,944 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Context 2 Clear all

Conditions: Quadrivalent HPV Vaccine, Human Papillomavirus Vaccine
Interventions: quadrivalent human papillomavirus vaccine; Biological
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 26 Years · Male only
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Obesity
Interventions: classroom curriculum, In-service training for Head Start teachers/aides, Training for Head Start food service, Family intervention component, Food source, Health care providers, CHILE Head Start Intervention; Behavioral
Lead sponsor: University of New Mexico; Other
Eligibility: 3 Years to 5 Years
Enrollment: 980 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Sepsis
Interventions: Bilateral phrenic nerve stimulation and measurement of transdiaphragmatic pressure, Midazolam, Volitional Measurement of Maximal Inspiratory Pressure (MIP), Inspiratory Muscle Strength Training (IMST), SHAM Inspiratory Muscle Strength Training (IMST), Diaphragm thickness measurement, Blood and Urine samples; Procedure · Drug · Device + 1 more
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Breast Cancer
Interventions: Fulvestrant; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: Female only
Enrollment: 179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 7
States / cities: Little Rock, Arkansas • Boston, Massachusetts • Winchester, Massachusetts + 4 more

Conditions: Opioid Dependence
Interventions: CI-581-a, CI-581-b; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV Infection
Interventions: Patient Mentor Intervention, HIV transmission risk reduction; Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 460 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Breast Cancer
Interventions: DPX-Survivac, Letrozole 2.5mg, Cyclophosphamide 50mg, XRT 10Gy x2; Biological · Drug · Radiation
Lead sponsor: Providence Health & Services; Other
Eligibility: 18 Years and older · Female only
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Metastatic HER2+ Advanced Breast Cancer
Interventions: Tucatinib, Trastuzumab, Capecitabine; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: Cancer Patients, Family Caregivers
Interventions: Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C), Emotion Regulation Therapy for Cancer Caregivers (ERT-C); Other
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 348 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 5
States / cities: Irvine, California • Boston, Massachusetts • New York, New York

Conditions: Acute Inflammatory Response to Psychological Stress
Interventions: Socio-evaluative speech task, Control, Quiet Rest; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 20 Years to 50 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Allergic Rhinitis, Sinusitis
Interventions: QHSLab Digital Tools (AME and ARIS); Other
Lead sponsor: QHSLab, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: West Palm Beach, Florida

Conditions: Smoking Cessation
Interventions: Take a Break as an augmentation to NRT-sampling in Motivation Phase, NRT and mHealth assessment tool without feedback; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 433 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 4
States / cities: Worcester, Massachusetts • Great Neck, New York

Conditions: Aphasia, Acquired
Interventions: Conversation Treatment for Aphasia; Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years to 85 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 3
States / cities: Boston, Massachusetts • Maywood, New Jersey • Philadelphia, Pennsylvania

Conditions: Psychotic Disorders, Bipolar Disorders, Suicidal Ideation, Suicide, Attempted
Interventions: SUicide Prevention by Peers Offering Recovery Tactics; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Congestive Heart Failure, Emotions, Patient Compliance
Interventions: PP-based health behavior intervention, MI-based educational control condition; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Alcohol Use, Adolescent, Mild Alcohol Use Disorder, Mild Substance Use Disorder
Interventions: Teen Intervene - Adolescent Only, Teen Intervene with Caregiver Session, Family Check Up; Behavioral
Lead sponsor: Indiana University; Other
Eligibility: 12 Years to 18 Years
Enrollment: 615 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Glaucoma
Interventions: Baerveldt Glaucoma Implant 350-mm2 / BG101-350, Transscleral Diode Laser Cyclophotocoagulation, Ahmed Model FP7 Flexible Plate, Baerveldt Glaucoma Implant 250-mm2 / BG103-250; Device · Procedure
Lead sponsor: Robert Feldman; Other
Eligibility: 18 Years to 85 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 23
States / cities: La Jolla, California • Los Angeles, California • Miami, Florida + 18 more

Conditions: Posttraumatic Stress Disorder
Interventions: Targeted Assessment and Context-Tailored Implementation of Change Strategies (TACTICS), Prolonged exposure training; Behavioral
Lead sponsor: Palo Alto Veterans Institute for Research; Other
Eligibility: Not listed
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 8
States / cities: Fairbanks, Alaska • Fairfield, California • Jacksonville, Florida + 5 more

Conditions: Smoking Cessation
Interventions: Telephone counseling, Voucher, Nicotine patches; Behavioral · Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 3,706 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Diego, California

Conditions: T-Cell Lymphoma
Interventions: Brentuximab vedotin, Pembrolizumab; Drug
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 2
States / cities: New Haven, Connecticut • Boston, Massachusetts

Conditions: Type 2 Diabetes Mellitus, Serious Mental Illness, Schizophrenia, Major Depression, Bipolar Disorder
Interventions: Lifestyle MIND; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 65 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Sleep, Sleep Hygiene
Interventions: Timed evening technology and digital media use (tablet use), no technology and digital media use (screen media use); Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 48 Months to 59 Months
Enrollment: 170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Type 1 Diabetes
Interventions: Predictive Low Glucose Management Feature in Insulin pump; Device
Lead sponsor: Medtronic MiniMed, Inc.; Industry
Eligibility: 14 Years to 75 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 8
States / cities: Escondido, California • Stanford, California • Walnut Creek, California + 5 more

Conditions: COVID-19
Interventions: AZD3152, Placebo; Drug · Other
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 4
States / cities: Anniston, Alabama • Cullman, Alabama • Scottsdale, Arizona + 1 more

Search by objective public record fields.

Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting

Child Health Initiative for Lifelong Eating and Exercise (CHILE)

Project 4A: Inspiratory Muscle Training and Diaphragm Strength

Fulvestrant (FASLODEX™) as a Treatment in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer

Facilitating Rapid Naltrexone Initiation

Test of an Intervention to Improve HIV Care

Neoadjuvant DPX-Survivac Aromatase Inhibition, Radiotherapy or Cyclophosphamide in HR+HER2- Breast Cancer

Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-DXd) for the Treatment of HER2-positive Metastatic Breast Cancer.

A Study Comparing Two Types of Supportive Interventions for Caregivers of Patients With Cancer

Biological Response to Brief Psychological Challenge

Harnessing Digital Medicine to Improve Allergic Rhinitis Management in Primary Care (DMAR)

Take a Break (TAB): mHealth-assisted Skills Building Challenge for Unmotivated Smokers

Conversation Group Treatment for Aphasia: Does it Work?

A Novel Peer-Delivered Recovery-Focused Suicide Prevention Intervention for Veterans With Serious Mental Illness

Researching Emotions And Cardiac Health: Phase III

Evaluating Caregiver Involvement in Primary Care-Based Brief Interventions for Adolescent Alcohol Use Problems

The American Glaucoma Society (AGS) Second Aqueous Shunt Implant vs. Transscleral Cyclophotocoagulation Treatment Study (ASSISTS)

Targeted Strategies to Accelerate Evidence-Based Psychotherapy (EBP) Implementation in Military Settings

Providing Free Nicotine Patches to Quitline Smokers

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

Lifestyle MIND- Feasibility of Wait-list Control

The Goodnight Screen Media Study

In Clinic Evaluation of the PLGM Feature

Dose Exploration Intramuscular/Intravenous Prophylaxis Pharmacokinetic Exposure Response Study